FindTrial
Sign In

Comparison of effectiveness of pain relief between Injection Magnesium Sulphate and Injection Butorphanol used as additives to Injection Bupivacaine heavy for spinal anesthesia in women undergoing lower abdominal gynecological surgery.

A COMPARATIVE STUDY OF INTRATHECAL MAGNESIUM SULPHATE VERSUS INTRATHECAL BUTORPHANOL AS ADJUVANT TO HYPERBARIC BUPIVACAINE IN ELECTIVE INFRAUMBILICAL GYNAECOLOGICAL SURGERY. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097810
Enrollment
50
Registered
2025-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N809- Endometriosis, unspecified Health Condition 3: N819- Female genital prolapse, unspecified Health Condition 4: N926- Irregular menstruation, unspecified Health Condition 5: N839- Noninflammatory disorder of ovary,fallopian tube and broad ligament, unspecified Health Condition 6: N832- Other and unspecified ovarian cysts

Interventions

Intervention1: INTRATHECAL BUTORPHANOL AS ADJUVENT TO HYPERBARIC BUPIVACAINE IN ELECTIVE INFRAUMBILICAL GYNAECOLOGICAL SURGERY: 50 Patients of ASA I or II physical status, aged 20-55year , undergoing

Sponsors

Department of Anesthesiology, North Bengal Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patient posted for elective gynecological surgery Age 20 to 55yrs ASA 1 ,2 BMI 18.5 to 24.9

Exclusion criteria

Exclusion criteria: Refusal of patients to undergo this study History of hypersensitivity to any of the medications used in the study Active neurological, cardiac, respiratory, blood dyscrasias, renal disease, any contraindication of subarachnoid block Patients with dyselectrolytemias Surgery duration of more than 3 hrs. Spinal deformity Pregnant patients

Design outcomes

Primary

MeasureTime frame
Time of sensory and motor block,total duration of motor and sensory block,time for first rescue analgesia.Timepoint: 1 year—

Secondary

MeasureTime frame
Quality of the block both sensory and motor (modified Bromage) and VAS scale for requirement of rescue analgesia.Monitoring of vital Spo2, SBP, DBP, PR Comparison of any other notifiable adverse event like desaturation, severe hypotension, bradycardia etc. as well as any sedation, cardiac arrythmias, pruritus, hypersensitivity reaction. Timepoint: 1 year—

Countries

India

Contacts

Public ContactAbhishek Ganguly

North Bengal Medical College and Hospital

abhi_here4u@yahoo.com9831404520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026